Pfizer Lipitor counterfeit crackdown
Executive Summary
Pfizer directs FDA to three lots of counterfeit Lipitor (atorvastatin) recalled by Albers Medical Distributors. Pfizer's help is part of an agreement between Pharmaceutical Research & Manufacturers of America member companies and FDA that companies will alert FDA Office of Criminal Investigations of suspected counterfeit drugs within five working days (1"The Pink Sheet" April 28, 2003, In Brief)...